Agios Pharmaceuticals Q2 EPS $(1.51) Beats $(1.60) Estimate, Sales $6.71M Beat $6.67M Estimate
Portfolio Pulse from Benzinga Newsdesk
Agios Pharmaceuticals reported Q2 earnings per share of $(1.51), beating the estimate of $(1.60) by 5.63%. This is a 10.12% increase over the same period last year. The company also reported quarterly sales of $6.71M, beating the estimate of $6.67M by 0.63%, a 20.24% increase over the same period last year.
August 04, 2023 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Agios Pharmaceuticals reported better than expected Q2 earnings and sales, which could positively impact the stock.
Agios Pharmaceuticals reported better than expected Q2 earnings and sales. This is generally seen as a positive signal by the market and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100